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Abstracts / Osteoarthritis and Cartilage 27 (2019) S92eS516 S289ﬁve were different at the time of ACL reconstruction surgery, six were
different 6 months post-surgery, and eight were different 12 months-
post surgery. L-methionine, Glyoxylic acid, and Malonic acid concen-
trations were signiﬁcantly lower across all time points in ACL injured
cases compared to uninjuredmatched controls. L-Lysine concentrations
were signiﬁcantly higher in ACL injured cases across all time points.
Succinic acid concentrations were signiﬁcantly higher in ACL injured
cases at the time of injury and at 6 months and 12months post-surgery.
Arachidonic acid concentrations were signiﬁcantly higher in ACL
injured cases at the time of injury, the time of surgery, and 12 months
post-surgery. The total percentage of explained variance by the ﬁrst two
principal components was 55.0% at the time of ACL injury, 58.0% at the
time of ACL reconstruction surgery, 59.8% at 6months post-surgery, and
56.6% 12 months post-surgery. As demonstrated in the ﬁgure, modest
separation was observed between ACL injured cases and uninjured
matched controls at the ﬁrst two time points (time of injury and sur-
gery) and notable separationwas observed at the latter two time points
(6 months and 12 months post-surgery). The proportion of cumulative
explained variance with the ﬁrst four principal components improved
to 78.2% to 84.5% across all time points.
Conclusions: Plasma concentrations for several metabolites appear to
differentiate between ACL injured cases and uninjured controls
matched for sex, age, height, and weight. This differentiation between
groups appears to improve at 6 and 12 months following ACL recon-
struction. The metabolites identiﬁed may provide insight into the
pathways associated with the initiation and progression of post-trau-
matic osteoarthritis following ACL injury; however, further research
and longer term follow-up in this cohort is needed to conﬁrm this.
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A SYSTEMATIC REVIEW OF THE SECRETOME OF SKELETAL MUSCLE
CELLS
A. Florin 1, C. Lambert 1, C. Sanchez 1, A. Mobasheri 2, Y. Henrotin 1. 1Bone
and Cartilage Res. Unit, Arthropo^le Liege, Univ. of Liege, CHU Sart-Tilman,
Belgium, Liege, Belgium; 2Dept. of Regenerative Med., State Res. Inst. Ctr.
for Innovative Med., Vilnius, Lithuania., Vilnius, LithuaniaPurpose: Proteomic studies of the secretome of skeletal muscle cells
will help to understand the processes that govern the synthesis and
organization of skeletal muscle. In this review, we have summarized
recent mass-spectrometry based proteomics discoveries of skeletal
muscle cells in response to disease, exercise or metabolic stress.
Methods: A literature search was performed in the Pubmed/Medline
and Scopus electronic databases, focusing on articles published
between July 2004 and May 2018. Only papers published in English and
reporting the analysis of the secretome of isolated skeletal muscle
myoblasts or of skeletal muscle explants of all species by mass spec-
trometry were included.
Results: A total of 17 papers were identiﬁed and analyzed. Published
research included comparative analysis of differentially expressed
proteins between healthy and unhealthy (Duchenne muscular dys-
trophy and insulin-resistant cells) muscle cells and comparison of the
secretome of skeletal muscle cells during myogenesis and after insulin
stimulation or exercising. The proteins were separated into several
categories (extracellular matrix, growth factors and cytokines, enzymes,
enzymatic inhibitors, cytoskeletal and miscellaneous proteins) and
their differential secretion was compared and important differences
were highlighted. In total, 288 proteins were listed in this systematic
review as being present in the secretome of muscle cells. Among them,
11 proteins were differentially regulated by physical exercise (all
upregulated), 28 during myogenesis (3 up- and 25 downregulated), 27
by insulin stimulation (14 up- and 13 downregulated) and ﬁnally 164
proteins secreted by insulin-resistant muscle cells (20 up- and 144
downregulated).
Conclusions: This systematic review of the secretome of skeletal
muscle cell in health and diseases provides a comprehensive overview
of the most regulated myokines in pathological conditions. These
myokines may be therapeutic targets or biochemical markers of muscle
diseases.
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EXPLORATORY PROTEOMICS OF HUMAN SYNOVIAL FLUID IN KNEE
OSTEOARTHRITIS: TOWARDS BIOMARKER IDENTIFICATION
N. Ali 1, J. Tj€ornstand 2, P. Neuman 2, E. Folkesson 1, V. Hughes 1,
P. €Onnerfjord 3, M. Englund 1. 1Clinical Epidemiology Unit, Orthopedics,
Dept. of Clinical Sci., Lund Univ., Lund, Sweden; 2Dept. of Orthopedics,
Skåne University Hospital, Sweden; 3Molecular Skeletal Biology, Section
for Rheumatology, Dept. of Clinical Sci., Lund Univ., Lund, Sweden
Purpose: There is a lack of valid and robust biomarkers in the ﬁeld of OA
diagnosis, prognosis, and treatment evaluation. Thus, our aim was to
performmass spectrometry (MS) of human synovial ﬂuid using a global
discovery approach, to identify biomarker candidates associated with
meniscus degradation and/or knee OA.
Methods: Synovial ﬂuid was sampled from 3 different subject groups: i)
end-stage medial compartment knee OA patients undergoing arthro-
plasty (n¼11, 3 men, 8 women; age range 55-80 years), ii) knee
arthroscopy patients who had knee symptoms but no or only minor
knee trauma, typically having a degenerativemeniscal tear (n¼7, 3men,
5 women; age range 50-64 years), and iii) deceased human donors
(within 48 hours post mortem) without known chronic knee disease
(n¼13, 8 men, 5 women; age range 19-79 years). These 3 groups were
roughly assumed to represent i) end-stage knee OA, ii) early knee OA,
and iii) healthy controls, respectively. For all 3 groups, we required no
visual signs of blood contamination to be present in the synovial ﬂuid.
For the cadaver knee tissues (controls), we further required the
meniscus and the weight-bearing femoral surface of cartilage/bone to
be macroscopically intact. All synovial ﬂuids were centrifuged and
freshly frozen and stored at -80C. For the analysis, 50 mL of synovial
ﬂuid from each sample was mixed with MS-safe proteinase inhibitor
cocktail and hyaluronidase, and further depleted of the 7 most abun-
dant proteins with the multiple afﬁnity removal system (MARS Hu7
spin cartridge). After reduction and alkylation, the samples were pre-
cipitated and the pellets were further digested with sequencing grade
trypsin (Promega. Following digestion, samples were cleaned with a
30kDa ﬁlter and desalted. The samples were further spiked with iRT
peptides before analysis by MS. The samples were analyzed with an
EASY-nLC 1000 coupled to an Orbitrap Fusion mass spectrometer. The
samples were analyzedwith data-independent acquisition settings. The
raw MS data were further analyzed with Spectronaut™ software for
protein identiﬁcation and quant data extraction. The quant data
extracted using Spectronaut™ were further imported into the R
